12:00 AM
 | 
Jul 01, 2013
 |  BC Week In Review  |  Company News  |  Other News

J&J, Multiple Myeloma Research Foundation (MMRF) cancer news

Johnson & Johnson's Janssen Research & Development LLC subsidiary joined the MMRF's Personalized Medicine Initiative (PMI), which includes the foundation's CoMMpass study to advance the development of personalized medicine for multiple myeloma (MM). MMRF launched the study in 2011 to follow 1,000...

Read the full 186 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >